Walleye Capital’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Buy
183,909
+151,022
+459% +$1.5M 0.01% 1472
2026
Q1
$303K Buy
32,887
+7,924
+32% +$65.9K ﹤0.01% 3059
2025
Q4
$185K Buy
24,963
+11,200
+81% +$76.7K ﹤0.01% 3573
2025
Q3
$93.5K Buy
+13,763
New +$93.2K ﹤0.01% 3737
2024
Q4
Sell
-11,846
Closed -$86.8K 5612
2024
Q3
$86.8K Buy
+11,846
New +$84.6K ﹤0.01% 4447
2023
Q4
Sell
-15,448
Closed -$104K 5567
2023
Q3
$104K Sell
15,448
-823
-5% -$6.74K ﹤0.01% 3922
2023
Q2
$159K Buy
+16,271
New +$165K ﹤0.01% 3221

Other funds holding VMD

Walleye Capital's VMD Position: Q2 2026 in Review

Walleye Capital increased its Viemed Healthcare (VMD) stake by 459% in Q2 2026, buying an estimated $1.5M and bringing the position to 183,909 shares worth $2.1M. The position accounts for 0.01% of the portfolio, ranked #1472.

Walleye Capital first reported a position in VMD in Q2 2023 and has held it in 7 quarters since. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Walleye Capital held 183,909 shares of Viemed Healthcare worth $2.1M as of Q2 2026.
  • Walleye Capital bought 151,022 Viemed Healthcare shares in Q2 2026, an estimated $1.5M.
  • Viemed Healthcare made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1472 holding.
  • Walleye Capital first reported a position in Viemed Healthcare in Q2 2023 and has held it in 7 quarters since.
  • 167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.